CLINICAL_TRIALS
trial_result
· 2012-06-06
Clinical Trial Update: Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer [Phase 2]
Summary
This document reports the completion of a Phase 2 clinical trial evaluating irinotecan in patients with metastatic or recurrent breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED